Antimicrobial Resistance in Diarrhea Treatment: Addressing Future Challenges in Africa
Nassimbwa Kabanda D.
Faculty of Medicine Kampala International University Uganda
ABSTRACT
Antimicrobial resistance (AMR) in the treatment of diarrheal diseases represents a significant and escalating public health challenge in sub-Saharan Africa. The region is particularly vulnerable due to factors such as poor sanitation, inadequate diagnostic infrastructure, and the overuse of antibiotics in both healthcare and agriculture. This review explores the impact of AMR on the management of common diarrheal diseases caused by pathogens like Shigella, E. coli, and Salmonella. It highlights the drivers of resistance, including the indiscriminate use of antibiotics, lack of regulatory oversight, and insufficient healthcare resources. The emergence of resistant strains complicates treatment options, resulting in prolonged illness, higher mortality rates, and strained healthcare systems. This review also discusses potential strategies to address AMR, such as strengthening diagnostic capabilities, implementing antibiotic stewardship programs, improving sanitation, and promoting public awareness. The findings underscore the need for a coordinated, multi-sectoral approach to combat AMR and preserve the effectiveness of current antimicrobial treatments in sub-Saharan Africa.
Keywords: Antimicrobial Resistance, Diarrheal Diseases, Sub-Saharan Africa, Antibiotic Stewardship.
CITE AS: Nassimbwa Kabanda D. (2026). Antimicrobial Resistance in Diarrhea Treatment: Addressing Future Challenges in Africa. IDOSR JOURNAL OF BIOCHEMISTRY, BIOTECHNOLOGY AND ALLIED FIELDS 11(1):102-106. https://doi.org/10.59298/IDOSR/JBBAF/2026/102101106